I have wanted to attend the  Annie Appleseed conference for the last 3 years but wasn't able to, until now. At the beginning of this month, I flew into West Palm Beach, visited with my mom for a couple of days and attended Annie's 4^th Annual Evidence-Based Complementary and Alternative Cancer Therapies Conference. We learned all about natural therapies, lifestyle issues and complementary, alternative, integrative and holistic cancer care, not only for breast cancer but other cancers as well. They served only organic food, mainly vegan with a choice of chicken or fish, and highly ionized and alkaline water for the 2 days of the conference. I felt so good during those 2 days!

Read the summary of the conference

Pink-Link Nutrition Expert Janice Baker discusses tried and true tips on getting more sleep!

"In my nutrition consultation and therapy practice, one of the first questions I ask all of my clients is: "how is your sleep?"  This may sound like an odd question coming from a registered dietitian, but more and more reasons to consider the effects of poor quality or lack of sleep are popping up all the time!"

MRI screening for breast cancer delivers consistent rates of cancer detection and fewer false-positive results over time, according to a new study published in the journal Radiology.

 

While MRI can be more effective than mammography at identifying suspicious areas of the breast, it is not always able to distinguish between cancerous and benign lesions, which can result in additional testing and false-positive results that may cause anxiety for patients. A screening exam is considered to be false positive when its results recommend further testing or a biopsy of a suspicious finding, but no cancer is found.

Scientists have discovered a new way breast cancer cells dodge the immune system and promote tumor growth, providing a fresh treatment target in the fight against the disease. While comparable mechanisms to avoid the immune system have been identified in mice with breast and other cancers, the study tested human breast tumor cells, putting researchers closer to understanding how the disease progresses in real patients.